Mitomycin-C in laser sclerostomy: Benefit and complications

Ophthalmic Surgery and Lasers

Volumn 28, Issue 1, 1997, Pages 14-20

  Schmidt Erfurth, Ursula ^a,e   Wetzel, Wolfgang ^b,d   Dröge, Gerit ^c   Birngruber, Reginald ^c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c MEDICAL LASER CENTER LÜBECK   (Germany)

^d Eye Surgery Center   (Germany)

^e UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DEXAMETHASONE; EYE DROPS; METHYLCELLULOSE; MIOTIC AGENT; MITOMYCIN C; PILOCARPINE; SODIUM CHLORIDE;

ADULT; ARGON LASER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERBIUM YAG LASER; GLAUCOMA SURGERY; HOLMIUM LASER; HUMAN; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; LASER SURGERY; MAJOR CLINICAL STUDY; OPEN ANGLE GLAUCOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RISK BENEFIT ANALYSIS; TOPICAL DRUG ADMINISTRATION; TRABECULOPLASTY;

ADMINISTRATION, TOPICAL; ANTIBIOTICS, ANTINEOPLASTIC; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LASER SURGERY; MITOMYCIN; OCULAR HYPOTENSION; OPHTHALMIC SOLUTIONS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SCLEROSTOMY;

EID: 0031044149     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Gherezghiher T, March W, Koss MC, Nordquist RE. Neodymium:YAG laser sclerostomy in primates. Arch Ophthalmol. 1985;103:1543-1545.
2. Hoskins HD, Iwach AG, Vassiliadis A, Drake MV, Hennings DR. Subconjunctival THC:YAG laser thermal sclerostomy. Ophthalmology. 1991;98:1394-1399.
3. Iwach AG, Hoskins HD, Drake MV, Dickens CJ. Subconjunctival THC:YAG (Holmium) laser thermal sclerostomy ab externo: a one year report. Ophthalmology. 1993;100:356-365.
4. Schuman JS, Stinson WG, Hutchinson T, Bellows AR, Puliafito CA, Lytle R. Holmium laser sclerotomy: success and complications. Ophthalmology. 1993;100: 1060-1065.
5. Watts P, Mc Allister J. Holmium laser sclerostomies: how well do they work? A two year follow-up. Lasers Light Ophthalmol. 1994;6:99-105.
6. Wetzel W, Schmidt-Erfurth U, Haring G, Roider J, Droge G, Birngruber R. Laser sclerostomy ab externo using two different infrared lasers: a clinical comparison. Ger J Ophthalmol. 1995;4:1-6.
7. Dürr U, Fankhauser F, England C, et al. Experimental Nd:YAG, diode and Ho:YAG laser sclerostomy performed ab inferno and ab externo. Lasers Light Ophthalmol. 1992;5:83-93.
8. March WF, Gherezghiher T, Koss MC. Histologic study of a neodymium:YAG laser sclerostomy. Arch Ophthalmol. 1985;103:860-863.
9. The Fluorouracil Filtering Surgery Study Group. Fluorouracil Filtering Surgery Study: one year follow-up. Am J Ophthalmol. 1989;108:625-635.
10. Kitazawa Y, Kawase K, Mitsushita H, Minobe M. Trabeculectomy with mitomycin: a comparative study with fluorouracil. Arch Ophthalmol. 1991;109: 1693-1698.
11. Shuta GL, Beeson CC, Higginbotham EJ. Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology. 1992;99:438-444.
12. Karp CL, Higginbotham EL, Griffin EO. Mitomycin C in ab-externo diode laser sclerostomy surgery in rabbits. Ophthalmic Surg. 1994;25:22-27.
13. Derick RJ, Pasquale L, Quigley HA, Jampel H. Potential toxicity of mitomycin C. Ophthalmology. 1991;109:1635.
14. Weiss HS, Nordlund JR. Subconjunctival mitomycin C without filtration surgery in blind human eyes. Invest Ophthalmol Vis Sci. 1994;35:1426.
15. Kawase K, Mitsushita H, Yamamoto T, Kitezawa Y. Mitomycin concentration in rabbit and human ocular tissue after topical administration. Ophthalmology. 1992;99:203.
16. Krott R, Mietz H, Diestelhorst M, Theisohn M, Rumpp AFE, Kriegistein GK. Intraocular concentrations of mitomycin C in the rabbit model: relations to total amount and concentration. Invest Ophthalmol Vis Sci. 1994;35:1426.
17. Sarraf D, Eezzeduemhoi D, Queng Q, Wilson MR, Lee DA. Aqueous and vitreous concentration of mitomycin C by topical administration after glaucoma filtration surgery in rabbits. Ophthalmology. 1993;100: 1574-1579.
18. Kee C, Peizek CD, Kaufman PL. Mitomycin C suppression of aqueous humor flow in cynomolgus monkeys. Invest Ophthalmol Vis Sci. 1994;35:1899.
19. Braccio L, Vecchi M, Gandolfi SA. Decrease of intraocular pressure after subconjunctival injection of mitomycin C in human glaucoma. Invest Ophthalmol Vis Sci. 1994;35:1899.
20. Stamper RL, Mc Menemy MG, Lieberman MF. Hypotonous maculopathy after trabeculectomy with subconjunctival 5-FU. Am J Ophthalmol. 1992;114: 544-553.
21. Hrdlicka ZK, Beckman RL, Welcome BA, Buzitta D, Preoperative subconjunctival mitomycin C as an adjunct to erbium laser sclerostomy: a dose response study. Invest Ophthalmol Vis Sci. 1994;35:1428.
22. Rubinfeld RS, Pfister RR, Stein RM. Serious complications of topical mitomycin C after pterygium surgery. Ophthalmology. 1992;99:1647-1654.
23. Hitchings RA. Primary surgery for primary open angle glaucoma: justified or not? Br J Ophthalmol. 1993; 77:445-448.
24. Broadway DC, Grierson J, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication: 1. The conjunctival cell profile. Arch Ophthalmol. 1994;112:1437-1445.
25. Broadway DC, Grierson J, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication: 2. The outcome of filtration surgery. Arch Ophthalmol. 1994;112:1446-1454.
26. Jay JL, Murray SB. Early trabeculectomy versus conventional management in primary open angle glaucoma. Br J Ophthalmol. 1988;72:881-889.
27. Migdal C, Hitchings RA. Control of chronic simple glaucoma with primary medical, laser, and surgical treatment. Trans Ophthalmol Soc UK. 1986;105: 653-656.